Literature DB >> 18474442

Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549.

Yoshiki Kawai1, Fumitaka Wada, Yoshiaki Sugimura, Masatoshi Maki, Kiyotaka Hitomi.   

Abstract

Transglutaminase is a Ca2+-dependent enzyme catalyzing protein cross-linking reactions. We investigated the contribution of this enzyme to the resealing of the injured plasma membrane in animal cells, using a lung cancer-derived cell line, A549. After mechanical injury by razor-scratching, the level of membrane resealing was estimated by differential incorporation of dextrans labeled with two distinct fluorescent dyes. The recovery level was decreased in the presence of excess primary amine, as a competitive inhibitor of transglutaminase. We established a cell line that stably expresses shRNA (short hairpin RNA) to specifically inhibit the expression of TGase 2 (tissue-type isozyme of transglutaminase) and confirmed the suppressed resealing level in the cell. Furthermore, additional expression of TGase 2 rescued the ability for membrane resealing. These results show that, after mechanical damage, this enzyme appeared to contribute to membrane resealing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474442     DOI: 10.1016/j.cellbi.2008.04.009

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  10 in total

1.  Transglutaminase 2: a new player in bronchopulmonary dysplasia?

Authors:  Thilo J Witsch; Gero Niess; Elpidoforos Sakkas; Tatyana Likhoshvay; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Eur Respir J       Date:  2014-03-06       Impact factor: 16.671

Review 2.  Above the fray: Surface remodeling by secreted lysosomal enzymes leads to endocytosis-mediated plasma membrane repair.

Authors:  N W Andrews; M Corrotte; T Castro-Gomes
Journal:  Semin Cell Dev Biol       Date:  2015-10-01       Impact factor: 7.727

3.  Transglutaminase 2 and its role in pulmonary fibrosis.

Authors:  Keith C Olsen; Ramil E Sapinoro; R M Kottmann; Ajit A Kulkarni; Siiri E Iismaa; Gail V W Johnson; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

4.  Identification of genes involved in biofilm formation and respiration via mini-Himar transposon mutagenesis of Geobacter sulfurreducens.

Authors:  Janet B Rollefson; Caleb E Levar; Daniel R Bond
Journal:  J Bacteriol       Date:  2009-04-24       Impact factor: 3.490

Review 5.  Two-way traffic on the road to plasma membrane repair.

Authors:  Vincent Idone; Christina Tam; Norma W Andrews
Journal:  Trends Cell Biol       Date:  2008-10-09       Impact factor: 20.808

6.  Transglutaminase 2 in cancer.

Authors:  Lei Huang; A-Man Xu; Wei Liu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

7.  Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation.

Authors:  Jeroen van den Akker; Angela van Weert; Gijs Afink; Erik N T P Bakker; Edwin van der Pol; Anita N Böing; Rienk Nieuwland; Ed VanBavel
Journal:  Amino Acids       Date:  2011-08-10       Impact factor: 3.520

8.  Cementoin-SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI.

Authors:  Paulo C Maffía; Diego Guerrieri; Ximena Villalonga; Fiorella Caro; Sonia Gómez; Nancy Tateosian; Betiana P Bogado; Mercedes L Sánchez; Nella Ambrosi; Eduardo Chuluyan
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

9.  Multiple Parameters Beyond Lipid Binding Affinity Drive Cytotoxicity of Cholesterol-Dependent Cytolysins.

Authors:  Sucharit Ray; Roshan Thapa; Peter A Keyel
Journal:  Toxins (Basel)       Date:  2018-12-21       Impact factor: 4.546

10.  Cardiomyocyte damage control in heart failure and the role of the sarcolemma.

Authors:  Ashraf Kitmitto; Florence Baudoin; Elizabeth J Cartwright
Journal:  J Muscle Res Cell Motil       Date:  2019-09-13       Impact factor: 2.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.